We chose three markers, soluble tumor necrosis factor receptor-1 (sTNFR1), interleukin-8 (IL8), and angiopoietin-2 (Ang2), which are easily measurable, associate with sepsis outcomes, and represent pathways that are potential targets for sepsis therapy [16–22]. This evidence concerns the gene CXCL8 and Sepsis.